DB15807InvestigationalVaccines
BBIBP-CorV vaccine contains a SARS-CoV-2 strain inactivated inside Vero Cells. Investigation shows this vaccine induces neutralizing antibodies in several mammalian species while also showing protective efficacy with SARS-CoV-2 challenge in... As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.
- Also known as
- Inactivated novel coronavirus (2019-CoV) vaccine (Vero cells) · Purified inactivated SARS-CoV-2 Vaccine
- Code names
- BBIBP-CorV
What you can answer from here — as of September 13, 2020
Which companies are running trials of BBIBP-CorV, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account